Year: 2006
Type: editorial
Abstract: It's almost a decade since the whole genome sequence of the tubercle bacillus M. tuberculosis was completed.The genome sequence of tuberculosis (TB) bacteria has opened various new avenues for studying biology of TB as well as heralded major funding possibilities for researchers worldwide.However, it is pathetic to realize that we do not have ready a 'promising' new drug target, a 'perfect' vaccine candidate or a 'gold standard' diagnostic marker as yet, for this dreaded pestilence.Countries like India are worst sufferers of such a disappointingly delayed fruit of post-genomic TB research and technology.Nonetheless, significant benefits arising in terms of exploratory genomics have helped the clinical cause of tracking and analyzing the strains of epidemic potential.Gutierrez and colleagues [1] in a recently reported multicentric research based on genotyping of TB strains prevalent in modern day India pointed to reservoirs of the ancestral strains, which continue to predominate throughout the population.
Authors: Niyaz Ahmed, Hakan Leblebicioglu
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,190
OpenAlex ID: W2095660524